Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FT4PY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,980
Award facts
- Contract value 100% obligated
- $21,979.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors with a ceiling value of $21,979.60 under a firm fixed-price arrangement. The award, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a non-competitive delivery order utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's Conshohocken, Pennsylvania location. Dupixent (dupilumab) is a biologic medication primarily indicated for atopic dermatitis, asthma, and eosinophilic conditions, addressing specialized pharmaceutical needs within the Defense Health Agency's medical supply chain.
This delivery order is issued under AmerisourceBergen's larger IDC vehicle (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support contract enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills delivery orders through open competition and demonstrates significant capability in managing both high-volume and specialized pharmaceutical requirements across multiple therapeutic domains for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FT4PY?
SPE2DR26FT4PY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FT4PY worth?
The government has obligated $21,980 on SPE2DR26FT4PY.
Is contract SPE2DR26FT4PY an order under another contract?
Yes. SPE2DR26FT4PY is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT4PY competed?
The extent of competition for SPE2DR26FT4PY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award